DNA sequencing (Sequencing) Archives

Molecular Dx

First Blood Test for Dozens of Hereditary Cancers Approved by FDA

Malorye Branca -

October 2, 2023

Molecular Dx

DNA Barcoding Allows Nanopore Sequencing to Identify Dozens of Biomarkers in One Test

Chris Anderson -

September 25, 2023

News & Features

Advanced Ovarian Cancer Regimen Plus Personalized Vaccine Doubles Survival Time

Chris Anderson -

September 22, 2023

Molecular Dx

Nanopore and U of Queensland Partner on mRNA Vaccine and Drug Testing

Malorye Branca -

September 21, 2023

News & Features

Long-Read Sequencing Uncovers Genetic Variants in Rare Kidney Disease

Christina Jackson -

August 24, 2023

Molecular Dx

Engineered Bacteria Can Detect Tumor DNA

Alisa Kirkin -

August 11, 2023

Molecular Dx

New Method Identifies Conserved Noncoding Mutations as Potential Drivers of Medulloblastoma

Sophia Ktori -

August 9, 2023

Molecular Dx

FDA Promotes Open Marriages for CDx and Therapeutics

Kathy Vuksanaj -

August 8, 2023

Molecular Dx

Can Precision Pregnancy Save More Mothers?

Malorye Branca -

August 8, 2023

News & Features

Leveraging the Full Potential of Sensitive Circulating Tumor DNA Analyses

Kathy Vuksanaj -

August 7, 2023

12 3...63 Page 1 of 63

Precision Medicine Navigators Increase Rates of Genetic Testing in Black Prostate…

First Blood Test for Dozens of Hereditary Cancers Approved by FDA

FDA Begins Program to Speed Up Development of Rare Disease Therapeutics

COVID-19 Causes Heart Attack and Stroke by Inflaming Arterial Plaque

EEG-Based Model Predicts Antidepressant Response

DNA sequencing (Sequencing)

First Blood Test for Dozens of Hereditary Cancers Approved by FDA

DNA Barcoding Allows Nanopore Sequencing to Identify Dozens of Biomarkers in One Test

Advanced Ovarian Cancer Regimen Plus Personalized Vaccine Doubles Survival Time

Nanopore and U of Queensland Partner on mRNA Vaccine and Drug Testing

Long-Read Sequencing Uncovers Genetic Variants in Rare Kidney Disease

Engineered Bacteria Can Detect Tumor DNA

New Method Identifies Conserved Noncoding Mutations as Potential Drivers of Medulloblastoma

FDA Promotes Open Marriages for CDx and Therapeutics

Can Precision Pregnancy Save More Mothers?

Leveraging the Full Potential of Sensitive Circulating Tumor DNA Analyses

Related Content

FDA Begins Program to Speed Up Development of Rare Disease Therapeutics

Genetic Variation in MASLD Suggests Precision Treatment Approaches

Midline Gliomas Show Immune Response to Novel Vaccine

Chromosomal Instability-Caused DNA Damage Increases Cancer Cell Invasiveness